Intravenous infusion is a brief outpatient procedure (20–45 minutes). Acute side effects (fever, transient joint pain, fatigue flare) may occur in 5–10% of recipients within 48 hours. Symptom assessment requires weeks to months because fibromyalgia itself fluctuates. Many advocates recommend concurrent physiotherapy, cognitive behavioural therapy, or medication adjustment, so isolating the cell-therapy effect is challenging.
Only 1 completed trial and 0 actively recruiting trials are registered specifically for fibromyalgia cell therapy, reflecting the early, exploratory stage of this application. That single published study involved placental MSC infusion in a small cohort (n≈20–30) and reported modest improvements in pain scores (average 20–30% reduction on visual analogue pain scale) and some improvement in fatigue severity. Biochemical markers of inflammation (IL-6, TNF-α) showed trending reductions. No control arm was present, and long-term follow-up was not reported.
我是候选人吗？ → · Fibromyalgia & Chronic Fatigue: full overview → · 纤维肌痛症和慢性疲劳综合征成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估